Capricor Therapeutics is trading at $9.45, up 10.27% after hours, with no clear company-specific catalyst identified. - The company is scheduled to present HOPE-3 and extension data at the World Muscle Society Congress, running September 29–October 3; the event was previously announced, and no new result was reported. - Available market context does not show a broad-market move large enough to explain the gain, so the reason for the after-hours rise remains unclear.